Evidence map›Paper›PMID 40585178›Full record

ArticlemedRxiv : the preprint server for health sciences2025

Bridging Neuroimaging and Neuropathology: A Comprehensive Workflow for Targeted Sampling of White Matter Lesions.

Nadim Farhat, Jinghang Li, Jacob Berardinelli, Mark Stauffer, Andrea Sajewski, Salem Alkhateeb, Noah Schweitzer, Jin Hecheng, Milos Ikonomovic, Jr-Jiun Liou and 6 more

Abstract readPreprint
In one paragraph

Article in medRxiv : the preprint server for health sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors.

Nadim FarhatUniversity of Pittsburgh, Department of Bioengineering, Pittsburgh, PA, US.
Jinghang LiUniversity of Pittsburgh, Department of Bioengineering, Pittsburgh, PA, US.ORCID 0000-0002-5340-8291
Jacob BerardinelliUniversity of Pittsburgh, Department of Bioengineering, Pittsburgh, PA, US.ORCID 0009-0007-3428-4821
Mark StaufferUniversity of Pittsburgh School of Medicine, Department of Pathology, Pittsburgh, PA, US.
Andrea SajewskiUniversity of Pittsburgh, Department of Bioengineering, Pittsburgh, PA, US.
Salem AlkhateebUniversity of Pittsburgh, Department of Bioengineering, Pittsburgh, PA, US.
Noah SchweitzerUniversity of Pittsburgh, Department of Bioengineering, Pittsburgh, PA, US.ORCID 0000-0003-2959-7851
Jin HechengUniversity of Pittsburgh, Department of Bioengineering, Pittsburgh, PA, US.ORCID 0000-0002-9855-2481
Milos IkonomovicUniversity of Pittsburgh School of Medicine, Department of Neurology, Pittsburgh, PA, US.
Jr-Jiun LiouUniversity of Pittsburgh, Department of Bioengineering, Pittsburgh, PA, US.ORCID 0000-0002-8800-9557
Howard J AizensteinUniversity of Pittsburgh, Department of Bioengineering, Pittsburgh, PA, US.
Joseph MettenburgUniversity of Pittsburgh School of Medicine, Department of Radiology, Pittsburgh, PA, US.
Tales SantiniUniversity of Pittsburgh, Department of Bioengineering, Pittsburgh, PA, US.ORCID 0000-0003-4533-9190
Minjie WuUniversity of Pittsburgh School of Medicine, Department of Psychiatry, Pittsburgh, PA, US.
Julia KoflerUniversity of Pittsburgh School of Medicine, Department of Pathology, Pittsburgh, PA, US.
Tamer S IbrahimUniversity of Pittsburgh, Department of Bioengineering, Pittsburgh, PA, US.ORCID 0000-0001-6738-5855

Funding

Project 3: Biomarkers for DS Clinical TrialsU19AG068054 · NIA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI CHRISTIAN, BRADLEY T · 2020 to 2025
$103.7M
Vascular Moderators of the Impact of Alzheimer's Pathology in the Young-OldP01AG025204 · NIA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI HOWARD J AIZENSTEIN, Ann D. Cohen · 2005 to 2026
$56.5M
CARDIOVASCULAR BEHAVIORAL MEDICINE RESEARCH TRAININGT32HL007560 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Peter J Gianaros, REBECCA C THURSTON · 1985 to 2026
$11.3M
Imaging Advancements in Small Vessel and CSF Flow Pathophysiology of Pre-clinical Alzheimer's DiseaseR01AG063525 · NIA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI AIZENSTEIN, HOWARD J, COHEN, ANN D. · 2019 to 2023
$3.7M
High Performance Imaging for Assessment of Small Vessel Disease in Older Adults with DepressionR01MH111265 · NIMH · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI AIZENSTEIN, HOWARD J, IBRAHIM, TAMER S · 2016 to 2020
$3.6M
Bioengineering in Psychiatry Training ProgramT32MH119168 · NIMH · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI AIZENSTEIN, HOWARD J, IBRAHIM, TAMER S · 2019 to 2023
$1.1M
NHLBI NIH HHS T32 HL007560NIA NIH HHS P01 AG025204NIA NIH HHS R01 AG063525NIA NIH HHS U19 AG068054NIMH NIH HHS R01 MH111265NIMH NIH HHS T32 MH119168
6 · The paper itself

Abstract

Background and Purpose: White matter lesions are common imaging biomarkers associated with aging and neurodegenerative diseases, yet their underlying pathology remains unclear due to limitations in imaging-based characterization. We aim to develop and validate a comprehensive workflow enabling precise MRI-guided histological sampling of white matter lesions to bridge neuroimaging and neuropathology. Methods: We establish a workflow integrating agarose-saccharose brain embedding, ultra-high field 7T MRI acquisition, reusable 3D-printed cutting guides, and semi-automated MRI-blockface alignment. Postmortem brains are stabilized in the embedding medium and scanned using optimized MRI protocols. Coronal sectioning is guided by standardized 3D-printed cutting guides, and knife traces are digitally matched to MRI planes. White matter lesions are segmented on MRI and aligned for histopathological sampling. This approach is validated in over 100 postmortem human brains. Results: The workflow enables reproducible brain sectioning, minimizes imaging artifacts, and achieves precise spatial alignment between MRI and histology. Consistent, high-resolution MRI data facilitated accurate lesion detection and sampling. The use of standardized cutting guides and alignment protocols reduce variability and improve efficiency. Conclusions: Our cost-effective, scalable workflow reliably links neuroimaging findings with histological analysis, enhancing the understanding of white matter lesion pathology. This framework holds significant potential for advancing translational research in aging and neurodegenerative diseases.

Indexed as

3D printingMRI-guided histologyneuroimaging workflowpostmortem brain imagingultra-high field MRIWhite matter lesions

Identifiers

PMID40585178
PMCPMC12204417

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.